Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

Williamson D, Missiaglia E, de Reyniès A, Pierron G, Thuille B, Palenzuela G, Thway K, Orbach D, Laé M, Fréneaux P, Pritchard-Jones K, Oberlin O, Shipley J, Delattre O.

J Clin Oncol. 2010 May 1;28(13):2151-8. doi: 10.1200/JCO.2009.26.3814. Epub 2010 Mar 29.

2.

Classification of rhabdomyosarcoma and its molecular basis.

Parham DM, Barr FG.

Adv Anat Pathol. 2013 Nov;20(6):387-97. doi: 10.1097/PAP.0b013e3182a92d0d. Review.

PMID:
24113309
3.

Molecular biology of rhabdomyosarcoma.

Gallego Melcón S, Sánchez de Toledo Codina J.

Clin Transl Oncol. 2007 Jul;9(7):415-9. Review.

PMID:
17652054
4.
5.

Childhood rhabdomyosarcoma: new insight on biology and treatment.

Huh WW, Skapek SX.

Curr Oncol Rep. 2010 Nov;12(6):402-10. doi: 10.1007/s11912-010-0130-3. Review.

PMID:
20820958
6.
7.

PAX3-FOXO1 fusion gene in rhabdomyosarcoma.

Linardic CM.

Cancer Lett. 2008 Oct 18;270(1):10-8. doi: 10.1016/j.canlet.2008.03.035. Epub 2008 May 23. Review.

8.

Histology and fusion status in rhabdomyosarcoma.

Rudzinski ER.

Am Soc Clin Oncol Educ Book. 2013:425-8. doi: 10.1200/EdBook_AM.2013.33.425. Review.

9.

Risk stratification of rhabdomyosarcoma: a moving target.

Arndt CA.

Am Soc Clin Oncol Educ Book. 2013:415-9. doi: 10.1200/EdBook_AM.2013.33.415. Review.

10.

Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis.

Kubo T, Shimose S, Fujimori J, Furuta T, Ochi M.

Crit Rev Oncol Hematol. 2015 Oct;96(1):46-53. doi: 10.1016/j.critrevonc.2015.04.012. Epub 2015 May 14. Review.

PMID:
26008753
11.

Decoding the 'embryonic' nature of embryonal rhabdomyosarcoma.

Lav R, Heera R, Cherian LM.

J Dev Orig Health Dis. 2015 Jun;6(3):163-8. doi: 10.1017/S204017441500015X. Epub 2015 Mar 5. Review.

PMID:
25740270
12.

Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.

Kashi VP, Hatley ME, Galindo RL.

Nat Rev Cancer. 2015 Jul;15(7):426-39. doi: 10.1038/nrc3961. Review.

Items per page

Supplemental Content

Write to the Help Desk